Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Humana Inc.

Humm Group Limited ( ($AU:HUM) ) has shared an update. Humm Group Limited has reported that the Federal Court of Australia has handed down judgment...

Humm Group Hit With $19m Court Damages in Forum Fraud Case but Escapes Larger SMBC Claim

An announcement from Humana AB ( ($SE:HUM) ) is now available. Humana AB has completed the acquisition of Norwegian care provider Familiehjelpgrupp...

Humana Completes Acquisition of Norwegian Care Provider Familiehjelpgruppen

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Quest Diagnostics (DGX – Research Report), Synergy CHC (SNYR – Re...

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Synergy CHC (SNYR) and Humana (HUM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eli Lilly & Co (LLY – Research Report), West Pharmaceutical Servi...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), West Pharmaceutical Services (WST) and Humana (HUM)

Memory chip stocks soared while software sank during the month. 


SNDK, MU, CRM: January’s Best and Worst-Performing Stocks

Health insurer stocks are under pressure today after investors reacted negatively to new Medicare pricing plans. The weakness follows a proposal fr...

UNH, CVS, HUM: Why Health Insurer Stocks Are Under Pressure Today

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Humana (HUM – Research Report), MannKind (MNKD – R...

Analysts Offer Insights on Healthcare Companies: Humana (HUM), MannKind (MNKD) and Inspire Medical Systems (INSP)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Humana (HUM – Research Report), Certara (CERT – Rese...

Analysts Offer Insights on Healthcare Companies: Humana (HUM), Certara (CERT) and Edgewise Therapeutics (EWTX)

Humana AB ( ($SE:HUM) ) has shared an announcement. Humana has signed an agreement with property owner Knut Olsson Fastigheter AB to establish a ne...

Humana Expands Elderly and LSS Care with New Central Sollentuna Facility

UnitedHealth ($UNH) is scheduled to release its fourth-quarter fiscal 2025 results before the market opens on January 27. Analysts expect the healt...

Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings?

RBC Capital analyst Ben Hendrix maintained a Buy rating on Humana yesterday and set a price target of $322.00. According to TipRanks, Hendrix is a ...

RBC Capital Sticks to Their Buy Rating for Humana (HUM)

Benchmark Co. analyst Bruce Jackson maintained a Buy rating on Humacyte today and set a price target of $10.00. According to TipRanks, Jackson is a...

Benchmark Co. Sticks to Its Buy Rating for Humacyte (HUMA)

Bernstein analyst Lance Wilkes maintained a Buy rating on Humana on January 16 and set a price target of $344.00. The company’s shares closed last ...

Bernstein Sticks to Their Buy Rating for Humana (HUM)

In a report released yesterday, Ann Hynes from Mizuho Securities maintained a Buy rating on Humana, with a price target of $310.00. The company’s s...

Humana (HUM) Gets a Buy from Mizuho Securities

Humm Group Limited ( ($AU:HUM) ) has issued an update. Humm Group Limited is confronting a shareholder-led attempt to overhaul its board, with acti...

Humm Board Urges Shareholders to Reject Activist-Led Director Shake-Up

The latest update is out from Humana AB ( ($SE:HUM) ). Humana’s Nomination Committee is proposing that the company’s Board of Directors for the 202...

Humana’s Nomination Committee Backs Full Board Re-Election and Continued Chairmanship

In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on Humana, with a price target of $344.00. According to TipRanks, W...

Bernstein Remains a Buy on Humana (HUM)

Complex securities class actions rarely end quickly, but when fundamental legal requirements remain unmet despite multiple attempts, even the most ...

Market Cap	$34.12B	P/E Ratio	10.97
52W High	$315.35	52W Low	$191.39
Div Yield	354.0%	Payout Ratio	67.4%
EPS Growth 3Y	N/A	52W Position	-3.4%
Overall Score	62	Value Score	100
Quality Score	55	Technical Score	33

EPS Current Est	$17.07	EPS Next Est	$12.1
EPS Growth Est	-29.1%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HUM	$187.20	-4.10%	2.81M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HUM	$187.20	-4.1%	2.81M
3
4
5
6

HUM

HUM

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Humana Inc. Data in Excel

Get Humana Inc. Data in Excel